KELLY-ANN KILCOLLINS: Open Payments
NPI 1073094843 · LAWRENCEVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 29 payments from 7 companies in 2025. Trend: 2023 $490 · 2024 $831 · 2025 $529
Food & beverage: $473Education: $56
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $161 |
| GlaxoSmithKline, LLC. | 7 | $114 |
| Optinose US, Inc. | 5 | $80 |
| GENZYME CORPORATION | 4 | $73 |
| Hikma Pharmaceuticals USA | 4 | $60 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: DUPIXENT, NUCALA, Xhance, Ryaltris, TEZSPIRE, VOQUEZNA.
Industry payments across NJ — which companies pay providers there.
